BR112016026599A2 - Sistema terapêutico transdérmico contendo óleo de lavanda, seu método de fabricação e seu uso - Google Patents

Sistema terapêutico transdérmico contendo óleo de lavanda, seu método de fabricação e seu uso

Info

Publication number
BR112016026599A2
BR112016026599A2 BR112016026599A BR112016026599A BR112016026599A2 BR 112016026599 A2 BR112016026599 A2 BR 112016026599A2 BR 112016026599 A BR112016026599 A BR 112016026599A BR 112016026599 A BR112016026599 A BR 112016026599A BR 112016026599 A2 BR112016026599 A2 BR 112016026599A2
Authority
BR
Brazil
Prior art keywords
therapeutic system
transdermal therapeutic
lavender oil
manufacturing
system containing
Prior art date
Application number
BR112016026599A
Other languages
English (en)
Other versions
BR112016026599B1 (pt
Inventor
Botzem Petra
Hille Thomas
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of BR112016026599A2 publication Critical patent/BR112016026599A2/pt
Publication of BR112016026599B1 publication Critical patent/BR112016026599B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0246—Adhesive bandages or dressings characterised by the skin-adhering layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00—Methods of manufacture, assembly or production
    • A61M2207/10—Device therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SISTEMA TERAPÊUTICO TRANSDÉRMICO CONTENDO ÓLEO DE LAVANDA. A invenção se refere a um sistema terapêutico transdérmico (TTS) contendo óleo de lavanda como a substância ativa e ao seu uso na profilaxia e/ou tratamento de estados de inquietação, distúrbios do sono, medos e nervosismo, principalmente de estados de inquietação em transtorno do medo. A invenção refere-se também a métodos de fabricação desse TTS, nos quais esse TTS é produzido sob uso de materiais de suporte feitos de componentes fibrosos e carregados com substância ativa por meio de um método de impressão.
BR112016026599-8A 2014-05-20 2015-05-08 Sistema terapêutico transdérmico contendo óleo de lavanda, seu método de fabricação e seu uso BR112016026599B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14169037.0A EP2946775A1 (de) 2014-05-20 2014-05-20 Lavendelöl enthaltendes transdermales therapeutisches System
EP14169037.0 2014-05-20
PCT/EP2015/000955 WO2015176801A1 (de) 2014-05-20 2015-05-08 Lavendelöl enthaltendes transdermales therapeutisches system

Publications (2)

Publication Number Publication Date
BR112016026599A2 true BR112016026599A2 (pt) 2017-08-15
BR112016026599B1 BR112016026599B1 (pt) 2023-06-06

Family

ID=

Also Published As

Publication number Publication date
RU2016149799A (ru) 2018-06-21
WO2015176801A8 (de) 2016-12-08
RU2695785C2 (ru) 2019-07-26
CN107073058A (zh) 2017-08-18
CA2949568C (en) 2023-12-12
CA2949568A1 (en) 2015-11-26
US20170080038A1 (en) 2017-03-23
KR20170009921A (ko) 2017-01-25
MX2016015185A (es) 2017-03-03
JP2017522269A (ja) 2017-08-10
EP3145501B1 (de) 2024-02-21
RU2016149799A3 (pt) 2018-10-25
WO2015176801A1 (de) 2015-11-26
JP7063537B2 (ja) 2022-05-09
ES2973862T3 (es) 2024-06-24
EP2946775A1 (de) 2015-11-25
EP3145501C0 (de) 2024-02-21
JP2021020959A (ja) 2021-02-18
EP3145501A1 (de) 2017-03-29

Similar Documents

Publication Publication Date Title
CL2015002708A1 (es) Compuestos heterocíclicos y sus usos.
DOP2016000286A (es) Compuesto heterocíclico que contiene nitrógeno
BR112015018104A2 (pt) polipeptídeos de gdf15 modificados, seu uso, composições compreendendo os mesmos e recipiente estéril compreendendo as referidas composições
CL2015002529A1 (es) Compuestos de tetrahidropirrolotiazina
BR112017002370A2 (pt) indóis para uso na infecção pelo vírus da gripe
BR112016026556A2 (pt) inibidores de mek, de p38 e/ou de nfkb, seus usos, composição, sistema de teste in vitro, seu uso, e método para detecção de moléculas eficazes na profilaxia e/ou tratamento de uma co-infecção
CO7141410A2 (es) Compuesto heterocíclico nitrogenado
CL2014000311A1 (es) Compuestos derivados de benzotiazepinas sustituidas; composicion farmaceutica que los contiene; y su uso para el tratamiento o profilaxis de la infeccion del virus sincicial respiratorio.
CL2015002434A1 (es) Moduladores benzoimidazol-2-il pirimidinas del receptor h4 de histamina.
ECSP16078782A (es) Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados
CL2016001076A1 (es) (aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis.
BR112017013607A2 (pt) ?método e dispositivo para o tratamento de alimentos e/ou recipientes por meio de um líquido de processo?
BR112017004153A2 (pt) métodos para tratamento de infecções por protozoários
EA201891783A1 (ru) Композиция для растворения аморфных дитиазинов и способ ее применения
CL2018001085A1 (es) Derivados de indolin-2-ona
BR112017008496A2 (pt) compostos para uso em tratamento antelmíntico
BR112015001619A2 (pt) manosídeos multiméricos, um processo para a preparação dos mesmos e as suas utilizações como um medicamento
CL2013001910A1 (es) Compuestos derivados de fenil-isoxazol; metodo para prepararlos; composicion farmaceutica que los comprende; combinacion que los comprende junto a otro agente terapeutico o preventivo de infecciones virales; metodo para prevenir o tratar infecciones virales; y su uso para el tratamiento de infecciones virales.
BR112018008931A2 (pt) ?compostos para tratamento de distúrbios hipoproliferativos?
BR112017022553A2 (pt) métodos e materiais para matar células infectadas por hiv
BR112015016033A8 (pt) composições farmacêuticas para tratamento de infecções por bactérias, e seus usos
BR112019017840A8 (pt) Método de inibir a isomerização de um sacarídeo redutor mediante tratamento térmico e uso de uma solução aquosa estéril
CO2017004785A2 (es) N-[4-(2-furil)-5-(tetrahidropiran-4-ilcarbonil)tiazol-2-il]-2-metilpiridin-5-carboxamida o una sal farmacéutica como antagonista del receptor a2a
CO2017003251A2 (es) Método para autentificación de líquido por detección de derivados de flavonoide
UY35650A (es) Compuesto heterocíclico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/05/2015, OBSERVADAS AS CONDICOES LEGAIS